bendamustine,mor00208,tafasitamab,polatuzumab vedotin,vedolizumab,lenalidomide
roche,morphosys,incyte,takeda,teva
['l-mind', 'polatuzumab', ' lena', 'bendamustine', 'lmind', 'lymsm', 'lymphoma', 'tafa ', ' pola ', 'dlbcl', ' vedo']
#ash22 real world outcomes in r/r #dlbcl #lymphoma who received pola-br or tafa-len by line of therapy #lymsm #rwe 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member